Salvatore Buscema is a results-driven commercial operations and sales executive with more than 25 years of experience leading high-growth product launches and organizational transformations across pharmaceuticals, specialty rare disease, consumer health, and emerging industries. He has spearheaded national and global commercialization strategies for market leaders including EpiPen, MUCINEX, and DELSYM, consistently delivering double-digit revenue growth and award-winning brand performance.

As Managing Director of BNB Business Solutions, Salvatore has guided multiple start-ups and specialty pharmaceutical firms through full-scale commercial buildouts, from salesforce deployment and compliance to analytics, payer initiatives, and specialty pharmacy partnerships. His career also includes senior leadership roles at Mylan, MiddleBrook Pharmaceuticals, and Adams Respiratory Therapeutics, where his sales leadership contributed to a $2.3B acquisition.

Beyond life sciences, Salvatore has also driven commercial strategy and organizational growth across technology, cybersecurity, insurance tech, artificial intelligence (with applications in healthcare and other verticals), aerospace, and construction. This breadth gives him a unique perspective on how to scale businesses in fast-changing, highly regulated, and competitive markets.

He is recognized for building high-performance teams, executing complex launches in oncology, hematology, cardiology, and neurology, and forging strategic partnerships that accelerate market access and operational efficiency. A Lehigh University graduate and former collegiate athlete, Salvatore brings a competitive spirit and proven ability to deliver lasting business impact.